Stericycle Inc (SRCL) Analysts See $1.15 EPS

October 13, 2017 - By reb123z

 Stericycle Inc (SRCL) Analysts See $1.15 EPS
Investors sentiment decreased to 0.94 in Q2 2017. Its down 0.18, from 1.12 in 2017Q1. It dived, as 48 investors sold Stericycle Inc shares while 185 reduced holdings. 62 funds opened positions while 158 raised stakes. 76.38 million shares or 1.92% less from 77.87 million shares in 2017Q1 were reported.
Eulav Asset Mgmt holds 139,700 shares. Old Mutual Customised Solutions (Proprietary) Limited owns 700 shares or 0.01% of their US portfolio. Cognios Capital reported 28,245 shares stake. Renaissance Ltd Liability invested 0.06% of its portfolio in Stericycle Inc (NASDAQ:SRCL). Cubist Systematic Strategies Ltd Company holds 0.09% or 18,642 shares. Telos Capital Management stated it has 0.57% of its portfolio in Stericycle Inc (NASDAQ:SRCL). Adage Cap Ptnrs Gp Ltd Liability Company invested in 0.01% or 73,100 shares. Wisconsin-based Mason Street Advisors Limited Liability Corp has invested 0.02% in Stericycle Inc (NASDAQ:SRCL). Cibc Asset invested in 9,287 shares. Wendell David Assoc Inc holds 0.43% or 29,732 shares. Aperio Ltd Llc holds 0.02% or 33,377 shares. The Illinois-based Bard Assoc Inc has invested 1.15% in Stericycle Inc (NASDAQ:SRCL). Sumitomo Mitsui Trust reported 235,220 shares. Bb&T reported 4,340 shares or 0.01% of all its holdings. Tennessee-based Delta Asset Mgmt Ltd Liability Corporation Tn has invested 0% in Stericycle Inc (NASDAQ:SRCL).

Wall Street await Stericycle Inc (NASDAQ:SRCL) to release earnings on October, 26. Analysts forecast EPS of $1.15, down exactly $0.09 or 7.26 % from 2014’s $1.24 EPS. The expected SRCL’s profit could reach $98.11 million giving the stock 15.49 P/E in the case that $1.15 earnings per share is reported. After posting $1.15 EPS for the previous quarter, Stericycle Inc’s analysts now forecast 0.00 % EPS growth. The stock increased 0.79% or $0.56 during the last trading session, reaching $71.27. About 816,712 shares traded or 28.38% up from the average. Stericycle Inc (NASDAQ:SRCL) has declined 14.12% since October 13, 2016 and is downtrending. It has underperformed by 30.82% the S&P500.

Stericycle Inc (NASDAQ:SRCL) Ratings Coverage

Among 15 analysts covering Stericycle (NASDAQ:SRCL), 5 have Buy rating, 3 Sell and 7 Hold. Therefore 33% are positive. Stericycle had 43 analyst reports since August 14, 2015 according to SRatingsIntel. As per Friday, October 23, the company rating was downgraded by Robert W. Baird. The stock of Stericycle Inc (NASDAQ:SRCL) earned “Sector Perform” rating by RBC Capital Markets on Friday, October 23. The stock has “Outperform” rating by Macquarie Research on Friday, October 23. The rating was maintained by Stifel Nicolaus on Sunday, August 13 with “Buy”. The firm earned “Buy” rating on Friday, October 23 by Stifel Nicolaus. The company was upgraded on Tuesday, September 8 by Raymond James. The firm has “Buy” rating by Sterne Agee CRT given on Tuesday, March 22. On Friday, August 11 the stock rating was maintained by Jefferies with “Buy”. The firm earned “Buy” rating on Friday, October 28 by Stifel Nicolaus. The firm has “Perform” rating by Oppenheimer given on Friday, October 23.

Stericycle, Inc. is a business-to-business services provider. The company has market cap of $6.08 billion. The Firm focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. It currently has negative earnings. The Company’s divisions include Domestic and Canada Regulated Waste and Compliance Services , Domestic Communication and Related Services (CRS), International RCS and All other.

More recent Stericycle Inc (NASDAQ:SRCL) news were published by: which released: “Stericycle Must Be Near A Bottom” on October 10, 2017. Also published the news titled: “Stericycle, Inc.” on October 12, 2017.‘s news article titled: “Scott+Scott, Attorneys at Law, LLP Is Investigating Derivative Claims on …” with publication date: October 04, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.